A

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy

European Journal of Cancer, vol. 239, pp. 116711

Authors 4

  1. The Netherlands Cancer Institute

    Affiliation as printed

    Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands

  2. The Netherlands Cancer Institute

    Affiliation as printed

    Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands

  3. The Netherlands Cancer Institute · Oncode Institute

    Affiliation as printed

    Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands

  4. Christian U. Blank corresponding Aachen

    Leiden University Medical Center · The Netherlands Cancer Institute · University Hospital Regensburg

    Affiliation as printed

    Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Hematology and Medical Oncology, University Clinic Regensburg (UKR), Germany. Electronic address: c.blank@nki.nl

Cited by 4 stored of 4

4 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 140